To address the functional capacity of sSig15 to suppress immune activity, we treated CD19-CAR expressing Jurkat cells with recombinant human Sig15 in coculture with a CD19+ B-ALL cell line. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.